Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, expectations were $3.87. Operator: Welcome to the Fourth Quarter 2024 Stryker ...

Medical and surgical device makers are riding on a surge in demand as more people in the U.S., particularly older Americans, ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Enfusion, Inc. (NYSE: ENFN )'s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to learn ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...